ArticlePloS one2014

E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.

Mengjie Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.